Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 


Natural killer cells are made, not born


First evidence of immune cell’s activation potential in infection, tumor control

In pursuit of natural killers: Guido Ferlazzo, Ph.D. (left), and Christian Münz, Ph.D., are proving that natural killers, a type of immune system cell, can be the body’s new gun for hire in tumor and infection control therapies. Münz became assistant professor and head of the Laboratory of Viral Immunology in December 2003.

Call it the immune system’s version of nature versus nurture.

... mehr zu:

For years, scientists regarded natural killer cells as a blunt instrument of the body’s immune defense system. Born to kill, these cells were thought to travel straight from the bone marrow, where they are manufactured, to the blood, circulating there and infiltrating the sites of early tumors or infectious agents in the body.

Now, Rockefeller University scientists, led by Christian Münz, Ph.D., have learned otherwise. Natural killer cells, Münz and his colleagues say, have to be nurtured. Their ability to destroy tumor and infected cells is not present at birth.

This new insight paves the road to changes in bone marrow and stem cell transplant procedures and will enable scientists to pursue research into activating natural killer cells to help the body fight emerging infections and tumors.

In two separate papers in the February issue of The Journal of Immunology, Münz, postdoctoral associate Guido Ferlazzo, Ph.D., and their colleagues show that natural killer cells accumulate mostly in "secondary lymphoid tissues" - the tonsils, lymph nodes and spleen - after emerging from the bone marrow. There, the natural killer cells await activation (probably after stimulation by sentinel dendritic cells) before they react in two distinct modes. In one mode, they promptly secrete cytokines, chemical messenger proteins, which modulate emerging T and B immune cell responses. In the other, they become potent killers of tumors and virus-infected cells. While natural killer cells do provide a crucial first defense against many infectious agents and tumor cells, they do so with more discrimination than raw determination.

"Natural killer cells burst forth from the the tonsils, lymph nodes and spleen, and destroy infected and cancerous cells while the immune system’s T and B cells are still mobilizing," says Münz. "Without natural killer cells, threatening conditions can get a strong foothold before the adaptive immune response kicks in."

Leading oncologists treating human leukemias and lymphomas already track natural killer cell activities after bone marrow and stem cell transplants. James Young, M.D., a researcher at Rockefeller’s neighboring Memorial Sloan-Kettering Cancer Center’s Allogenic Bone Marrow and Stem Cell Transplant Service, is one of them. "The emerging data on the activation of natural killer cells, their distinct functions in the body and their cellular targets, are helping to move the study of natural killer cells in transplantation and cancer from conjecture to sound hypotheses," he says.

The findings by Münz and his colleagues not only explain why a natural killer burst is important - the burst likely results from mobilization of natural killer cells from lymphoid tissues, and these activated immune cells are discriminating enough to recognize, through a full repertoire of surface receptors, virus-infected and tumor cells - it also affirms a potential strategic change in bone marrow or stem cell donor matching.

Bone marrow donors are selected based on the similarity of their white blood cell profiles: the closer the match to the patient, the better. But that’s likely less important when doctors can harness the donor’s natural killer cells to fight both residual cancer cells and residual immune system cells of the patient. Certain mismatches between donor and recipient can actually encourage the donor’s natural killer cells to deliver an extra punch to the cancer and the threatening graft-versus-host disease, the updated logic goes.

Münz and his colleagues did not develop the bone marrow donor match strategy, but part of their aim in understanding where and how natural killers hang out, was to determine how the cells are recruited to combat cancer and other emerging diseases in the body. The Rockefeller scientists are in close contact with clinicians interested in tailoring immune cells - such as natural killers - in treating human leukemias.

The current Journal of Immunology publications also contribute to strategies for dealing with the viral menace known as Epstein-Barr virus, a member of the herpes family of viruses. Though most infections are latent, active Epstein-Barr is the source of infectious mononucleosis in many teenagers.

Epstein-Barr also is a human cancer-causing virus. The virus hijacks the immune system’s B cells in an elaborate chemical signaling mimicry of normal B cells. The result often is B cell tumors like Hodgkin’s disease and Burkitt’s lymphoma. Münz and his colleagues know that the natural killer cell response, or burst, is important in establishing immune control against the cancer causing Epstein-Barr virus.

"We have seen that Epstein-Barr virus transformation of B cells can be delayed by a strong natural killer cell burst," says Münz. "Now we are studying how this herpes virus may be targeted by natural killer cell responses." By learning both what molecular signals activate natural killer cells in their dialogue with dendritic cells and how viruses can be targeted by natural killer cells, Münz and his colleagues may be able to artificially stimulate natural killer cells to heighten their effect and ward off emerging Epstein-Barr virus associated malignancies.

"We’re trying to get a sum of all signals that activate natural killer cells against viruses and tumors and do not cause harm to healthy human tissues," says Münz. "In the past five years, we’ve learned enough about these cells to extend hopes of their eventual usefulness in medical treatments."

This research was funded by the Leukemia & Lymphoma Society and the New York Academy of Medicine.

Lynn Love | Rockefeller University
Weitere Informationen:

Weitere Berichte zu: Immunology

Weitere Nachrichten aus der Kategorie Biowissenschaften Chemie:

nachricht Sterilkonnektoren der nächsten Generation
21.10.2016 | Pall Life Sciences BioPharmaceuticals Central Europe

nachricht Zweiter Forschungsflug in die Schwerelosigkeit
21.10.2016 | Universität Zürich

Alle Nachrichten aus der Kategorie: Biowissenschaften Chemie >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Die Quanten-Schnüffelnase

Der Laser, der zugleich ein Detektor ist: An der TU Wien wurde ein mikroskopisch kleiner Sensor entwickelt, mit dem man gleichzeitig verschiedene Gase nachweisen kann.

Wir Menschen erschnüffeln unterschiedliche Gerüche und Düfte durch chemische Rezeptoren in unserer Nase. Doch für den technischen Nachweis von Gasen greift man...

Im Focus: „Molekül-Selfie“ enthüllt den Aufbruch einer chemischen Bindung

Wissenschaftlern des Institute of Photonic Sciences (Barcelona) ist es gelungen, die Position aller Atome eines Moleküls zu verfolgen während der Aufbruch einer der chemischen Bindungen ein einzelnes Proton freisetzt. Hierzu wurde ein am Heidelberger Max-Planck-Institut für Kernphysik entwickeltes Reaktionsmikroskop verwendet [Science, 21. Oktober 2016].

Man stelle sich vor, die einzelnen Atome eines Moleküls ließen sich während einer chemischen Reaktion beobachten: Wie sie sich umlagern, um eine neue Substanz...

Im Focus: Elektronik mit Licht beschleunigen

Wissenschaftler am MPQ haben mit ultrakurzen Laserpulsen die schnellsten jemals erzeugten elektrischen Ströme in Festkörpern gemessen. Die Elektronen führten in einer Sekunde achtmillionen Milliarden Schwingungen aus, ein absoluter Rekord für die Steuerung von Elektronen in Festkörpern.

Die Leistungsfähigkeit von modernen elektronischen Geräten wie Computern oder Mobilfunkgeräten wird durch die Geschwindigkeit bestimmt, mit der die...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Innovative Lösungen für multifunktionale Werkstoffe und effiziente kurze Prozessketten

IPF Dresden präsentiert sich im Science Campus der Kunststoffmesse 2016

Auf der weltgrößten Kunststoffmesse K 2016 vom 19. bis 26. Oktober 2016 in Düsseldorf präsentiert sich das Leibniz-Institut für Polymerforschung Dresden e. V....

Alle Focus-News des Innovations-reports >>>



im innovations-report
in Kooperation mit academics

Experten treffen sich am 27. Oktober zum siebten „NORTH Regio Day on Infection“ in Braunschweig

20.10.2016 | Veranstaltungen

Sicherheit und Vertrauen in der vernetzten Welt

20.10.2016 | Veranstaltungen

Fachtagung „55. Heidelberger Grand Round“ mit internationalen Krebsexperten

20.10.2016 | Veranstaltungen

Weitere VideoLinks >>>
Aktuelle Beiträge

Die Quanten-Schnüffelnase

21.10.2016 | Energie und Elektrotechnik

Sterilkonnektoren der nächsten Generation

21.10.2016 | Biowissenschaften Chemie

Neuer Mechanismus hinter der Wirkung von Hautkrebs-Medikament Imiquimod entschlüsselt

21.10.2016 | Biowissenschaften Chemie